OPTOSURGICAL, LLC — Department of the Interior SBIR: SBIR PH II "TRANSLATION OF NOVEL BILIARY TRACT-SPECIFIC CONTRAST AGENT TO MEDIATE SUCCESSF
OPTOSURGICAL, LLC — SBIR award from Department of the Interior.
SBIR award competitive context
- Public SBIR obligation from Department of the Interior to OPTOSURGICAL, LLC. Use agency + tech-domain links below to map the broader competitive field.
- At $2,095,748, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Optosurgical, LLC won about $2.1 million in SBIR Phase II funding to turn a new contrast agent into a practical tool. The agent targets the biliary tract to make image-guided liver and bile-duct procedures safer and more successful.
- Amount
- $2,095,748
- Agency
- Department of the Interior · Departmental Offices
- Program / Phase
- SBIR
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- MD
- Period
- 2026-04-08 → 2029-01-09
Technology domains
Description
SBIR PH II "TRANSLATION OF NOVEL BILIARY TRACT-SPECIFIC CONTRAST AGENT TO MEDIATE SUCCESSFUL IMAGE-GUIDED HEPATOBILIARY INTERVENTIONS"